AI Tool Diagnoses Cancer, Guides Treatment and Predicts Survival Across Multiple Cancer Types
Scientists have developed a versatile AI model, similar to ChatGPT, that can handle a variety of diagnostic tasks across multiple cancer types and marks a significant improvement over many existing cancer diagnostic models. More...10 Sep 2024
Binding-Activated Fluorescent Biosensors Open Vast Possibilities for Medical Diagnostics
A synthetic biology platform simplifies the discovery, molecular evolution, and economical production of small, highly efficient nanosensors that can detect specific proteins, peptides, and small molecules with huge potential for diagnostics. More...09 Sep 2024
Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications
QIAGEN has entered into a collaboration with Eli Lilly to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) to detect APOE genotypes which can play a role in the diagnosis of Alzheimer’s disease. More...06 Sep 2024
In Other News
Rapid Dopamine Test to Enable Early Detection of Neurological Disorders
Long-Read Sequencing Technology to Identify Genetic Contributors of Rare Diseases in Children
Microarray Immunoassay Improves Accuracy and Speed of Celiac Disease Diagnosis
New Technique Enables Comprehensive Genetic Examination of Embryos with Single Test
Easy-To-Use Point-Of-Care Testing Device Accurately Measures Cortisol Levels in Blood
Blood-Based Test Allows for Minimally Invasive Detection of IDH1.R132H-Mutant Gliomas
Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis
New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay
Software Tool to Advance Cancer Pathology by Providing Diagnostic Insights from Tissue Biopsies
Single Blood Test Predicts 30-Year Cardiovascular Disease Risks for Women
AI Automates Analysis of Pathology Slides for Distinguishing Rheumatoid Arthritis Subtypes
Syphilis Assay Improves Lab Efficiency and Reduces Costs Through Earlier Disease Detection
QIAGEN and AstraZeneca Expand Collaboration into New Disease Areas
Ultra-Fast Test Screens for All Types of Cancer with Simple Blood Draw
Simpler, Faster Testing Technology to Boost Early Detection of Lyme Disease
Rapid Blood Test Diagnoses Brain Cancer in Less Than an Hour
New Blood Test to Transform Detection and Diagnosis of Alzheimer’s Disease
POCT Device Monitors C-Reactive Protein Levels Associated with Inflammation in Real Time
Novel Blood-Based Risk Score Based on Lipids Improves Prediction of Heart Disease
AI-Based Digital Pathology Platform Improves Lung Cancer Diagnosis
MEDICA 2024 + COMPAMED 2024: Adapted Hall Layout for Better Integration
Machine Learning-Powered Blood Test Estimates Age-Related Disease Risk
Roche Joins Fight Against Mpox Outbreak with High-Quality PCR Diagnostic Tests